What is the appropriate screening protocol in Lynch syndrome?

Familial Cancer

Volumn 5, Issue 4, 2006, Pages 373-378

  De Jong, A E ^a   Nagengast, F M ^b   Kleibeuker, J H ^c   Van De Meeberg, P C ^d   Van Wijk, H J ^e   Cats, A ^f   Griffioen, G ^a   Vasen, H F A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d SLINGELAND HOSPITAL   (Netherlands)

^e MÁXIMA MEDICAL CENTER   (Netherlands)

^f NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Colorectal Cancer; Lynch syndrome; Surveillance protocol

Indexed keywords

ADENOMA; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER REGISTRY; CANCER SCREENING; CANCER SURGERY; CHILD; COLONOSCOPY; COLORECTAL CANCER; ENDOSCOPY; FAMILIAL CANCER; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; PRIORITY JOURNAL; RELATIVE; RISK ASSESSMENT;

ADENOMA; ADULT; AGE FACTORS; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FOLLOW-UP STUDIES; HETEROZYGOTE; HUMANS; MIDDLE AGED; MUTATION;

EID: 33845530339     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-006-0008-6     Document Type: Article

References (24)

1. Mecklin JP (1987) Frequency of hereditary colorectal carcinoma. Gastroenterology 93(5):1021-1025
2. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK et al (1994) Mutation in the DNA mismatch repair gene homologue HMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368(6468):258-261
3. Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA et al (1994) Mutation of a MutL homolog in hereditary colon cancer. Science 263(5153):1625-1629
4. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J et al (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75(5):1027-1038
5. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R et al (1993) Mutations of a MutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75(6):1215-1225
6. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP et al (1993) Clues to the pathogenesis of familial colorectal cancer. Science 260(5109):812-816
7. Akiyama Y, Sato H, Yamada T, Nagasaki H, Tsuchiya A, Abe R et al (1997) Germ-line mutation of the HMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Res 57(18):3920-3923
8. Miyaki M, Konishi M, Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Yasuno M et al (1997) Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 17(3):271-272
9. Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, De La Chapelle A et al (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81(2):214-218
10. Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G et al (1996) Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110(4):1020-1027
11. Mecklin JP, Jarvinen HJ (1991) Tumor spectrum in cancer family syndrome (Hereditary Nonpolyposis Colorectal Cancer). Cancer 68(5):1109-1112
12. Vasen HF, Offerhaus GJ, Hartog Jager FC, Menko FH, Nagengast FM, Griffioen G et al (1990) The tumour spectrum in hereditary non-polyposis colorectal cancer: a study of 24 Kindreds in the Netherlands. Int J Cancer 46(1):31-34
13. Watson P, Lynch HT (1993) Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 71(3):677-685
14. Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P et al (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118(5):829-834
15. Vasen HF, Nagengast FM, Khan PM (1995) Interval cancers in hereditary non-polyposis colorectal cancer (Lynch Syndrome). Lancet 345(8958):1183-1184
16. Ahlquist DA (1995) Aggressive polyps in hereditary non-polyposis colorectal cancer: targets for screening. Gastroenterology 108(5):1590-1592
17. De Jong AE, Morreau H, van Puijenbroek M, Eilers PH, Wijnen J, Nagengast FM et al (2004) The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC. Gastroenterology 126(1):42-48
18. Jass JR, Stewart SM, Stewart J, Lane MR (1994) Hereditary non-polyposis colorectal cancer - morphologies, genes and mutations. Mutat Res 310(1):125-133
19. Weber T (1996) Clinical surveillance recommendations adopted for HNPCC
20. de Vos tot Nederveen Cappel WH, Nagengast FM, Griffioen G, Menko FH, Taal BG, Kleibeuker et al (2002) Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families. Dis Colon Rectum 45(12):1588-1594
21. Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A (2000) Colorectal Cancer Prevention 2000: screening recommendations of the American College of gastroenterology. American College of gastroenterology. Am J Gastroenterol 95(4):868-877
22. Vasen HF, Hartog Jager FC, Menko FH, Nagengast FM (1989) Screening for hereditary non-polyposis colorectal cancer: a study of 22 Kindreds in The Netherlands. Am J Med 86(3):278-281
23. Wijnen JT, Vasen HF, Khan PM, Zwinderman AH, van der Klift H, Mulder A et al (1998) Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 339(8):511-518
24. Wijnen J, de Leeuw W, Vasen H, van der Klift H, Moller P, Stormorken A et al (1999) Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet 23(2):142-144